COVID-19 and ENT SLT services, workforce and research in the UK: A discussion paper.
COVID-19
ENT SLT research
ENT SLT services
ENT SLT workforce
Journal
International journal of language & communication disorders
ISSN: 1460-6984
Titre abrégé: Int J Lang Commun Disord
Pays: United States
ID NLM: 9803709
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
21
05
2020
revised:
15
06
2020
accepted:
28
06
2020
pubmed:
10
8
2020
medline:
22
12
2020
entrez:
10
8
2020
Statut:
ppublish
Résumé
The COVID-19 pandemic and the UK government's subsequent coronavirus action plan have fundamentally impacted on every aspect of healthcare. One area that is severely affected is ear, nose and throat (ENT)/laryngology where speech and language therapists (SLTs) engage in a diverse range of practice with patients with a range of conditions, including voice disorders, airway problems, and head and neck cancers (HNCs). A large majority of these patients are in high-risk categories, and many specialized clinical practices are vulnerable. In addition, workforce and research issues are challenged in both the immediate context and the future. To discuss the threats and opportunities from the COVID-19 pandemic for SLTs in ENT/laryngology with specific reference to clinical practice, workforce and research leadership. The relevant sections of the World Health Organisation's (WHO) health systems building blocks framework (2007) were used to structure the study. Expert agreement was determined by an iterative process of multiple-group discussions, the use of all recent relevant policy documentation, and other literature and shared documentation/writing. The final paper was verified and agreed by all authors. The main threats to ENT/laryngology SLT clinical services include increased patient complexity related to COVID-19 voice and airway problems, delayed HNC diagnosis, reduced access to instrumental procedures and inequitable care provision. The main clinical opportunities include the potential for new modes of service delivery and collaborations, and harnessing SLT expertise in non-instrumental assessment. There are several workforce issues, including redeployment (and impact on current services), training implications and psychological impact on staff. Workforce opportunities exist for service innovation and potential extended ENT/SLT practice roles. Research is threatened by a reduction in immediate funding calls and high competition. Current research is affected by very limited access to participants and the ability to conduct face-to-face and instrumental assessments. However, research opportunities may result in greater collaboration, and changes in service delivery necessitate robust investigation and evaluation. A new national set of research priorities is likely to emerge. The immediate impact of the pandemic has resulted in major disruption to all aspects of clinical delivery, workforce and research for ENT/laryngology SLT. It is unclear when any of these areas will resume operations and whether permanent changes to clinical practice, professional remits and research priorities will follow. However, significant opportunity exists in the post-COVID era to re-evaluate current practice, embrace opportunities and evaluate new ways of working. What this paper adds What is already known on the subject ENT/laryngology SLTs manage patients with a range of conditions, including voice disorders, airway problems and HNCs. The diverse scope of clinical practice involves highly specialized assessment and treatment practices in patients in high-risk categories. A large majority of active research projects in this field are patient focused and involve instrumental assessment. The COVID-19 pandemic has created both opportunities and threats for ENT SLT clinical services, workforce and research. What this paper adds to existing knowledge This study provides a discussion of the threats and opportunities from the COVID-19 pandemic for ENT/laryngology SLT with specific reference to clinical practice, workforce and research leadership. What are the potential or actual clinical implications of this work? The COVID-19 pandemic has resulted in major disruption to all aspects of clinical delivery, workforce and research for ENT/laryngology SLT. Changes to clinical practice, professional remits and research priorities are of indeterminant duration at this time, and some components could be permanent. Significant clinical practice, workforce and research opportunities may exist in the post-COVID era.
Sections du résumé
BACKGROUND
The COVID-19 pandemic and the UK government's subsequent coronavirus action plan have fundamentally impacted on every aspect of healthcare. One area that is severely affected is ear, nose and throat (ENT)/laryngology where speech and language therapists (SLTs) engage in a diverse range of practice with patients with a range of conditions, including voice disorders, airway problems, and head and neck cancers (HNCs). A large majority of these patients are in high-risk categories, and many specialized clinical practices are vulnerable. In addition, workforce and research issues are challenged in both the immediate context and the future.
AIMS
To discuss the threats and opportunities from the COVID-19 pandemic for SLTs in ENT/laryngology with specific reference to clinical practice, workforce and research leadership.
METHODS & PROCEDURES
The relevant sections of the World Health Organisation's (WHO) health systems building blocks framework (2007) were used to structure the study. Expert agreement was determined by an iterative process of multiple-group discussions, the use of all recent relevant policy documentation, and other literature and shared documentation/writing. The final paper was verified and agreed by all authors.
MAIN CONTRIBUTION
The main threats to ENT/laryngology SLT clinical services include increased patient complexity related to COVID-19 voice and airway problems, delayed HNC diagnosis, reduced access to instrumental procedures and inequitable care provision. The main clinical opportunities include the potential for new modes of service delivery and collaborations, and harnessing SLT expertise in non-instrumental assessment. There are several workforce issues, including redeployment (and impact on current services), training implications and psychological impact on staff. Workforce opportunities exist for service innovation and potential extended ENT/SLT practice roles. Research is threatened by a reduction in immediate funding calls and high competition. Current research is affected by very limited access to participants and the ability to conduct face-to-face and instrumental assessments. However, research opportunities may result in greater collaboration, and changes in service delivery necessitate robust investigation and evaluation. A new national set of research priorities is likely to emerge.
CONCLUSIONS & IMPLICATIONS
The immediate impact of the pandemic has resulted in major disruption to all aspects of clinical delivery, workforce and research for ENT/laryngology SLT. It is unclear when any of these areas will resume operations and whether permanent changes to clinical practice, professional remits and research priorities will follow. However, significant opportunity exists in the post-COVID era to re-evaluate current practice, embrace opportunities and evaluate new ways of working. What this paper adds What is already known on the subject ENT/laryngology SLTs manage patients with a range of conditions, including voice disorders, airway problems and HNCs. The diverse scope of clinical practice involves highly specialized assessment and treatment practices in patients in high-risk categories. A large majority of active research projects in this field are patient focused and involve instrumental assessment. The COVID-19 pandemic has created both opportunities and threats for ENT SLT clinical services, workforce and research. What this paper adds to existing knowledge This study provides a discussion of the threats and opportunities from the COVID-19 pandemic for ENT/laryngology SLT with specific reference to clinical practice, workforce and research leadership. What are the potential or actual clinical implications of this work? The COVID-19 pandemic has resulted in major disruption to all aspects of clinical delivery, workforce and research for ENT/laryngology SLT. Changes to clinical practice, professional remits and research priorities are of indeterminant duration at this time, and some components could be permanent. Significant clinical practice, workforce and research opportunities may exist in the post-COVID era.
Identifiants
pubmed: 32770652
doi: 10.1111/1460-6984.12565
pmc: PMC7436215
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
806-817Subventions
Organisme : Department of Health
ID : CDRF-2013-04-020
Pays : United Kingdom
Organisme : Department of Health
ID : NIHR300427
Pays : United Kingdom
Informations de copyright
© 2020 The Authors. International Journal of Language & Communication Disorders published by John Wiley & Sons Ltd on behalf of Royal College of Speech and Language Therapists.
Références
Cochrane Database Syst Rev. 2019 Jul 23;7:CD013067
pubmed: 31335963
BMJ. 2020 Apr 2;369:m1297
pubmed: 32241766
Oral Oncol. 2013 Jun;49(6):507-24
pubmed: 23566773
Clin Otolaryngol. 2020 May;45(3):311-312
pubmed: 32246529
BMJ. 2020 Mar 24;368:m1150
pubmed: 32209559
Otolaryngol Head Neck Surg. 2011 Nov;145(5):767-71
pubmed: 21746839
Head Neck. 2020 Jul;42(7):1674-1680
pubmed: 32374942
BMJ. 2020 Mar 20;368:m1117
pubmed: 32198166
J Laryngol Otol. 2013 Nov;127(11):1116-21
pubmed: 24180639
J Voice. 2022 Mar;36(2):249-255
pubmed: 32600873
Curr Opin Otolaryngol Head Neck Surg. 2019 Jun;27(3):185-190
pubmed: 30893134
Int Arch Otorhinolaryngol. 2018 Jan;22(1):50-54
pubmed: 29371898
Ann Otol Rhinol Laryngol. 2019 Apr;128(4):345-351
pubmed: 30638026
Crit Care Med. 2018 Dec;46(12):2010-2017
pubmed: 30096101
Otolaryngol Head Neck Surg. 2018 Mar;158(1_suppl):S1-S42
pubmed: 29494321
Curr Opin Otolaryngol Head Neck Surg. 2017 Jun;25(3):195-199
pubmed: 28277335
Cancer. 2015 May 15;121(10):1608-19
pubmed: 25586197
Telemed J E Health. 2014 Apr;20(4):296-303
pubmed: 24443927
Head Neck. 2017 May;39(5):932-939
pubmed: 28225567
Int J Lang Commun Disord. 2019 Mar;54(2):292-305
pubmed: 30779425
J Voice. 2022 Mar;36(2):291.e9-291.e16
pubmed: 32600872
Oral Oncol. 2020 Jun;105:104684
pubmed: 32330858
J Asthma. 2015 May;52(4):327-35
pubmed: 25365113
Anaesthesia. 2020 Jul;75(7):972
pubmed: 32302417